Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 233
Ph III recruiting: 18
Growth YoY: +3.1%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.2%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 301–304 of 304 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04712305	Urine Omics Predicting IO Therapy Responses in mRCC Patients	recruiting	—	400	National Taiwan University HospitalOTHER	1	Jan 20, 2022	clinicaltrials
NCT03288532	Renal Adjuvant MultiPle Arm Randomised Trial(RAMPART)	recruiting	Phase 3	1,750	University College, LondonOTHER	1	Sep 7, 2020	clinicaltrials